Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (155) 155
male (136) 136
index medicus (67) 67
prostate cancer (65) 65
oncology (55) 55
animals (53) 53
aged (48) 48
article (44) 44
endocrinology & metabolism (43) 43
human necessities (43) 43
chemistry (42) 42
hygiene (42) 42
medical or veterinary science (42) 42
metallurgy (42) 42
preparations for medical, dental, or toilet purposes (42) 42
organic chemistry (41) 41
mice (38) 38
middle aged (37) 37
peptides (37) 37
prostatic neoplasms - pathology (35) 35
female (33) 33
cell line, tumor (32) 32
receptors, androgen - genetics (32) 32
expression (31) 31
adult (30) 30
cancer (30) 30
receptors, androgen - metabolism (30) 30
androgen receptor (29) 29
prostatic neoplasms - metabolism (26) 26
cell biology (25) 25
progression (25) 25
prostatic neoplasms - genetics (25) 25
prostate (24) 24
androgens (21) 21
gene expression regulation, neoplastic (21) 21
epithelial-cells (18) 18
gene expression (18) 18
abiraterone (17) 17
castration (17) 17
cells (17) 17
insulin (17) 17
signal transduction (17) 17
biochemistry (16) 16
biochemistry & molecular biology (16) 16
specific therapeutic activity of chemical compounds ormedicinal preparations (16) 16
testosterone - blood (16) 16
enzalutamide (15) 15
microbiology (15) 15
prostatic neoplasms - drug therapy (15) 15
prostatic neoplasms, castration-resistant - drug therapy (15) 15
research (15) 15
apoptosis (14) 14
receptor, igf type 1 - genetics (14) 14
tumor cells, cultured (14) 14
aged, 80 and over (13) 13
beer (13) 13
enzymology (13) 13
estradiol - blood (13) 13
increased survival (13) 13
mice, nude (13) 13
mutation or genetic engineering (13) 13
spirits (13) 13
vinegar (13) 13
wine (13) 13
analysis (12) 12
cell proliferation (12) 12
luteinizing hormone - blood (12) 12
metastasis (12) 12
receptor, igf type 1 - metabolism (12) 12
time factors (12) 12
transfection (12) 12
blotting, western (11) 11
culture media (11) 11
dose-response relationship, drug (11) 11
gene-expression (11) 11
growth (11) 11
health aspects (11) 11
insulin - blood (11) 11
tumors (11) 11
urology & nephrology (11) 11
xenograft model antitumor assays (11) 11
alternative splicing (10) 10
cell proliferation - drug effects (10) 10
compositions or test papers therefor (10) 10
compositions thereof (10) 10
condition-responsive control in microbiological orenzymological processes (10) 10
immunohistochemistry (10) 10
ligands (10) 10
measuring or testing processes involving enzymes, nucleicacids or microorganisms (10) 10
microorganisms or enzymes (10) 10
physiological aspects (10) 10
processes of preparing such compositions (10) 10
proliferation (10) 10
propagating, preserving or maintaining microorganisms (10) 10
prostatic neoplasms, castration-resistant - genetics (10) 10
prostatic neoplasms, castration-resistant - metabolism (10) 10
research article (10) 10
risk factors (10) 10
rna, messenger - genetics (10) 10
rna, messenger - metabolism (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (349) 349
French (15) 15
German (4) 4
Portuguese (4) 4
Spanish (3) 3
Russian (2) 2
Chinese (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clinical Significance of AR-V567es in Prostate Cancer—Letter
by Uo, Takuma and Plymate, Stephen R
Clinical Cancer Research, ISSN 1078-0432, 10/2019, Volume 25, Issue 19, pp. 6009 - 6009
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text AR Variant Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?
by Dehm, Scott M and Montgomery, Bruce and Plymate, Stephen R
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 12/2018
CTCs biomarkers may become indicators for selection of therapy. The presence of AR variant positive CTCs may be markers indicating need for switching therapy.... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Integrative Clinical Genomics of Advanced Prostate Cancer
by Robinson, Brian D and Robinson, Dan and Van Allen, Eliezer M and Wu, Yi-Mi and Schultz, Nikolaus and Lonigro, Robert J and Mosquera, Juan-Miguel and Montgomery, Bruce and Taplin, Mary-Ellen and Pritchard, Colin C and Attard, Gerhardt and Beltran, Himisha and Abida, Wassim and Bradley, Robert K and Vinson, Jake and Cao, Xuhong and Vats, Pankaj and Kunju, Lakshmi P and Hussain, Maha and Feng, Felix Y and Tomlins, Scott A and Cooney, Kathleen A and Smith, David C and Brennan, Christine and Siddiqui, Javed and Mehra, Rohit and Chen, Yu and Rathkopf, Dana E and Morris, Michael J and Solomon, Stephen B and Durack, Jeremy C and Reuter, Victor E and Gopalan, Anuradha and Gao, Jianjiong and Loda, Massimo and Lis, Rosina T and Bowden, Michaela and Balk, Stephen P and Gaviola, Glenn and Sougnez, Carrie and Gupta, Manaswi and Yu, Evan Y and Mostaghel, Elahe A and Cheng, Heather H and Mulcahy, Hyojeong and True, Lawrence D and Plymate, Stephen R and Dvinge, Heidi and Ferraldeschi, Roberta and Flohr, Penny and Miranda, Susana and Zafeiriou, Zafeiris and Tunariu, Nina and Mateo, Joaquin and Perez-Lopez, Raquel and Demichelis, Francesca and Schiffman, Marc and Nanus, David M and Tagawa, Scott T and Sigaras, Alexandros and Eng, Kenneth W and Elemento, Olivier and Sboner, Andrea and Heath, Elisabeth I and Scher, Howard I and Pienta, Kenneth J and Kantoff, Philip and de Bono, Johann S and Rubin, Mark A and Nelson, Peter S and Garraway, Levi A and Sawyers, Charles L and Chinnaiyan, Arul M
Cell, ISSN 0092-8674, 05/2015, Volume 161, Issue 5, pp. 1215 - 1228
Toward development of a precision medicine framework for metastatic, castration-resistant prostate cancer (mCRPC), we established a multi-institutional... 
HETEROGENEITY | INHIBITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | INCREASED SURVIVAL | MUTATIONS | REARRANGEMENTS | ETS GENE FUSIONS | CHEMOTHERAPY | DISCOVERY | ENZALUTAMIDE | ABIRATERONE | CELL BIOLOGY | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Neoplasm Metastasis - pathology | Humans | Gene Expression Profiling - methods | Male | Mutation | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Cohort Studies | Genetic research | Genetic aspects | Prostate cancer | Cancer | precision oncology | transcriptome sequencing | whole exome sequencing | prostate cancer genomics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants
by Mostaghel, Elahe A and Marck, Brett T and Plymate, Stephen R and Vessella, Robert L and Balk, Stephen and Matsumoto, Alvin M and Nelson, Peter S and Montgomery, R. Bruce
Clinical Cancer Research, ISSN 1078-0432, 09/2011, Volume 17, Issue 18, pp. 5913 - 5925
Purpose: Abiraterone is a potent inhibitor of the steroidogenic enzyme CYP17A1 and suppresses tumor growth in patients with castration-resistant prostate... 
ANTIANDROGEN | ONCOLOGY | STEROIDAL INHIBITORS | GROWTH | GENE-EXPRESSION | THERAPEUTIC IMPLICATIONS | CYTOCHROME P450(17-ALPHA) | ANTITUMOR-ACTIVITY | ACETATE | PROGRESSION | DEHYDROGENASE | Prostatic Neoplasms - metabolism | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Humans | Male | Gene Expression Profiling | Androstenols - therapeutic use | Biosynthetic Pathways - genetics | Prostatic Neoplasms - genetics | Gene Expression Regulation, Neoplastic - drug effects | Prostatic Neoplasms - drug therapy | Dihydrotestosterone - metabolism | Disease Models, Animal | Androgens - secretion | Alternative Splicing - genetics | Androstenols - pharmacology | Androstenes | Mice, SCID | Prostatic Neoplasms - mortality | Orchiectomy | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Receptors, Androgen - genetics | Cell Proliferation - drug effects | Mice | Androgens - metabolism | steroidogenesis | abiraterone | androgen receptor splice variant | castration resistant prostate cancer | CYP17A1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Response: letter to the editor
by Schweizer, Michael T and Plymate, Stephen R
Expert Opinion on Therapeutic Targets, ISSN 1472-8222, 02/2017, Volume 21, Issue 2, pp. 229 - 229
DEGRADATION | PHARMACOLOGY & PHARMACY | PROSTATE-CANCER | GALETERONE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Abstract C11: The role of immune cells and androgen receptor splice variant 567 exon-skipping in prostate cancer
by Hara, Jared HL and Plymate, Stephen R and Sprenger, Cynthia T
Cancer Research, ISSN 0008-5472, 08/2016, Volume 76, Issue 15 Supplement, pp. C11 - C11
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Integrative Clinical Genomics of Advanced Prostate Cancer
by Robinson, Dan and Robinson, Brian D and Van Allen, Eliezer M and Wu, Yi-Mi and Schultz, Nikolaus and Lonigro, Robert J and Mosquera, Juan-Miguel and Montgomery, Bruce and Taplin, Mary-Ellen and Pritchard, Colin C and Attard, Gerhardt and Beltran, Himisha and Abida, Wassim and Bradley, Robert K and Vinson, Jake and Cao, Xuhong and Vats, Pankaj and Kunju, Lakshmi P and Hussain, Maha and Feng, Felix Y and Tomlins, Scott A and Cooney, Kathleen A and Smith, David C and Brennan, Christine and Siddiqui, Javed and Mehra, Rohit and Chen, Yu and Rathkopf, Dana E and Morris, Michael J and Solomon, Stephen B and Durack, Jeremy C and Reuter, Victor E and Gopalan, Anuradha and Gao, Jianjiong and Loda, Massimo and Lis, Rosina T and Bowden, Michaela and Balk, Stephen P and Gaviola, Glenn and Sougnez, Carrie and Gupta, Manaswi and Yu, Evan Y and Mostaghel, Elahe A and Cheng, Heather H and Mulcahy, Hyojeong and True, Lawrence D and Plymate, Stephen R and Dvinge, Heidi and Ferraldeschi, Roberta and Flohr, Penny and Miranda, Susana and Zafeiriou, Zafeiris and Tunariu, Nina and Mateo, Joaquin and Perez-Lopez, Raquel and Demichelis, Francesca and Sboner, Andrea and Schiffman, Marc and Nanus, David M and Tagawa, Scott T and Sigaras, Alexandros and Eng, Kenneth W and Elemento, Olivier and Heath, Elisabeth I and Scher, Howard I and Pienta, Kenneth J and Kantoff, Philip and de Bono, Johann S and Rubin, Mark A and Nelson, Peter S and Garraway, Levi A and Sawyers, Charles L and Chinnaiyan, Arul M
Cell, ISSN 0092-8674, 07/2015, Volume 162, Issue 2, pp. 454 - 454
BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL BIOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer
by Hu, Rong and Lu, Changxue and Mostaghel, Elahe A and Yegnasubramanian, Srinivasan and Gurel, Meltem and Tannahill, Clare and Edwards, Joanne and Isaacs, William B and Nelson, Peter S and Bluemn, Eric and Plymate, Stephen R and Luo, Jun
Cancer Research, ISSN 0008-5472, 07/2012, Volume 72, Issue 14, pp. 3457 - 3462
Continued androgen receptor (AR) signaling is an established mechanism underlying castration-resistant prostate cancer (CRPC), and suppression of androgen... 
ONCOLOGY | EXPRESSION | PROGRESSION | ABIRATERONE | Neoplasms, Hormone-Dependent - metabolism | Phenylthiohydantoin - pharmacology | Protein Structure, Tertiary | Prostatic Neoplasms - metabolism | Signal Transduction | Androstenols - pharmacology | Humans | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Androstenes | Male | Transplantation, Heterologous | Ubiquitin-Conjugating Enzymes - genetics | Phenylthiohydantoin - analogs & derivatives | Animals | Prostatic Neoplasms - genetics | Protein Isoforms - metabolism | Receptors, Androgen - genetics | Castration | Cell Line, Tumor | Ligands | Transcription, Genetic | Mice | Prostatic Neoplasms - drug therapy | androgen receptor splice variants | MDV3100 | androgen receptor | abiraterone | castration-resistant prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Androgen receptor variants occur frequently in castration resistant prostate cancer metastases
by Zhang, Xiaotun and Morrissey, Colm and Sun, Shihua and Ketchandji, Melanie and Nelson, Peter S and True, Lawrence D and Vakar-Lopez, Funda and Vessella, Robert L and Plymate, Stephen R
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, p. e27970
Background: Although androgens are depleted in castration resistant prostate cancer (CRPC), metastases still express nuclear androgen receptor (AR) and... 
STEROIDOGENESIS | THERAPY | TESTOSTERONE | EPIDERMAL-GROWTH-FACTOR | BIOLOGY | GENE-EXPRESSION | FACTOR-I | BONE | CELL-LINES | SPLICE VARIANTS | PROGRESSION | Neoplasms, Hormone-Dependent - metabolism | Prostatic Neoplasms - metabolism | Prostatic Hyperplasia - pathology | Prognosis | Alternative Splicing | Humans | Middle Aged | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Male | Immunoenzyme Techniques | Prostate - metabolism | Bone Neoplasms - metabolism | Neoplasms, Hormone-Dependent - genetics | Prostate - pathology | Prostatic Neoplasms - genetics | Castration | Aged, 80 and over | Adult | Bone Neoplasms - genetics | Real-Time Polymerase Chain Reaction | Soft Tissue Neoplasms - genetics | Prostatic Neoplasms - pathology | Soft Tissue Neoplasms - secondary | RNA, Messenger - genetics | Soft Tissue Neoplasms - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Prostatic Hyperplasia - genetics | Blotting, Western | Prostatic Hyperplasia - metabolism | Receptors, Androgen - genetics | Neoplasms, Hormone-Dependent - pathology | Cell Line, Tumor | Aged | Proteins | Viral antibodies | Antibodies | Androgens | Metastasis | Prostate cancer | Alternative splicing | Phosphorylation | Staining | Kinases | Tissues | Urology | Metastases | Angiogenesis | Xenografts | Localization | Medical research | Lymphatic system | Immunoglobulins | Review boards | C-Terminus | Gene expression | Polymerase chain reaction | Chemotherapy | Ligands | Immunoreactivity | Prostate | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Abstract 285: Androgen receptor splice variants determine taxane sensitivity in prostate cancer
by Thadani-Mulero, Maria and Plymate, Stephen R and Giannakakou, Paraskevi
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 285 - 285
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
by Sun, Shihua and Sprenger, Cynthia C. T and Vessella, Robert L and Haugk, Kathleen and Soriano, Kathryn and Mostaghel, Elahe A and Page, Stephanie T and Coleman, Ilsa M and Nguyen, Holly M and Sun, Huiying and Nelson, Peter S and Plymate, Stephen R
Journal of Clinical Investigation, ISSN 0021-9738, 08/2010, Volume 120, Issue 8, pp. 2715 - 2730
Progression of prostate cancer following castration is associated with increased androgen receptor (AR) expression and signaling despite AR blockade. Recent... 
TUMOR-CELL LINES | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | EPITHELIAL-CELLS | IGF-IR | GENE-EXPRESSION | MUTATIONS | MEDICAL CASTRATION | PROGRESSION | GROWTH-FACTOR-I | T-ANTIGEN | Neoplasm Transplantation | Prostatic Neoplasms - pathology | Humans | Gene Expression Regulation, Neoplastic | Male | Transplantation, Heterologous | Orchiectomy | Prostatic Neoplasms - therapy | Neoplasm Metastasis | RNA Splicing | Animals | Prostatic Neoplasms - genetics | Receptors, Androgen - genetics | Androgen Antagonists - therapeutic use | Cell Line, Tumor | Mice | Hydroxamic Acids - pharmacology | Receptors, Androgen - physiology | Complications and side effects | Hormone receptors | Castration | Development and progression | Properties | Prostate cancer | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Androgen receptor splice variants determine taxane sensitivity in prostate cancer
by Thadani-Mulero, Maria and Portella, Luigi and Sun, Shihua and Sung, Matthew and Matov, Alexandre and Vessella, Robert L and Corey, Eva and Nanus, David M and Plymate, Stephen R and Giannakakou, Paraskevi
Cancer Research, ISSN 0008-5472, 04/2014, Volume 74, Issue 8, pp. 2270 - 2282
Prostate cancer growth depends on androgen receptor signaling. Androgen ablation therapy induces expression of constitutively active androgen receptor splice... 
STEROIDOGENESIS | DNA-BINDING | MITOXANTRONE | ANTIANDROGEN | ONCOLOGY | HINGE REGION | RESISTANCE | DOCETAXEL | PROGRESSION | ENZALUTAMIDE | ABIRATERONE | Taxoids - pharmacology | Microtubule-Associated Proteins - genetics | Humans | Receptors, Androgen - metabolism | Male | Prostatic Neoplasms, Castration-Resistant - genetics | Microtubules - metabolism | RNA Splicing | Cell Nucleus - metabolism | Transfection | HEK293 Cells | Disease Models, Animal | Protein Structure, Tertiary | Signal Transduction | Docetaxel | Dynactin Complex | Prostatic Neoplasms, Castration-Resistant - drug therapy | Mice, SCID | Microtubule-Associated Proteins - biosynthesis | Prostatic Neoplasms, Castration-Resistant - metabolism | Xenograft Model Antitumor Assays | Animals | Receptors, Androgen - genetics | Protein Isoforms | Cell Line, Tumor | Mice | Taxane | Androgen receptor variants | resistance to therapy | Prostate cancer | Androgen receptor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Capillary force seeding of sphere-templated hydrogels for tissue-engineered prostate cancer xenografts
by Long, Thomas J and Takeno, Marc and Sprenger, Cynthia C and Plymate, Stephen R and Ratner, Buddy D
Tissue Engineering - Part C: Methods, ISSN 1937-3384, 09/2013, Volume 19, Issue 9, pp. 738 - 744
Biomaterial-based tissue-engineered tumor models are now widely used in cancer biology studies. However, specific methods for efficient and reliable cell... 
PROLIFERATION | SCAFFOLDS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Tissue Scaffolds | Xenograft Model Antitumor Assays | Prostatic Neoplasms - pathology | Polyhydroxyethyl Methacrylate - pharmacology | Tissue Engineering - methods | DNA, Neoplasm - metabolism | Humans | Staining and Labeling | Cell Line, Tumor | Male | Mechanical Phenomena | Hydrogels - pharmacology | Biomedical materials | Hydrogels | Tissue engineering | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
by Henzler, Christine and Li, Yingming and Yang, Rendong and McBride, Terri and Ho, Yeung and Sprenger, Cynthia and Liu, Gang and Coleman, Ilsa and Lakely, Bryce and Li, Rui and Ma, Shihong and Landman, Sean R and Kumar, Vipin and Hwang, Tae Hyun and Raj, Ganesh V and Higano, Celestia S and Morrissey, Colm and Nelson, Peter S and Plymate, Stephen R and Dehm, Scott M
Nature Communications, ISSN 2041-1723, 11/2016, Volume 7, Issue 1, p. 13668
Molecularly targeted therapies for advanced prostate cancer include castration modalities that suppress ligand-dependent transcriptional activity of the... 
GENE | RNA-SEQ | MULTIDISCIPLINARY SCIENCES | MUTATION | RESISTANCE | SPLICE VARIANTS | EXPRESSION | PROGRESSION | DISCOVERY | ENZALUTAMIDE | ABIRATERONE | Humans | RNA, Messenger - genetics | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Exons - genetics | Male | Chromosomes, Human, Pair 11 - genetics | Gene Dosage | RNA, Messenger - metabolism | Prostatic Neoplasms, Castration-Resistant - genetics | Neoplasm Metastasis | Alleles | Cell Line, Tumor | Clone Cells | Gene Rearrangement - genetics | Genome, Human
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Molecular pathways: Targeting resistance in the androgen receptor for therapeutic benefit
by Mostaghel, Elahe A and Plymate, Stephen R and Montgomery, Bruce
Clinical Cancer Research, ISSN 1078-0432, 2014, Volume 20, Issue 4, pp. 791 - 798
Androgen receptor signaling is critical in the development and progression of prostate cancer, leading to intensive efforts to elucidate all potential points... 
HSP90 INHIBITORS | POLY(ADP-RIBOSE) POLYMERASE | ANTIANDROGEN | ONCOLOGY | ABIRATERONE ACETATE | INCREASED SURVIVAL | CELL-LINES | I CLINICAL-TRIAL | SPLICE VARIANTS | METASTATIC PROSTATE-CANCER | PROGRESSION | Prostatic Neoplasms - metabolism | Antineoplastic Agents, Hormonal - pharmacology | Signal Transduction | Humans | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Androgen Antagonists - pharmacology | Drug Resistance, Neoplasm | Male | Molecular Targeted Therapy | Prostatic Neoplasms - genetics | Receptors, Androgen - genetics | Antineoplastic Agents, Hormonal - therapeutic use | Androgen Antagonists - therapeutic use | Mutation | Prostatic Neoplasms - drug therapy | androgens | prostate cancer | androgen receptor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Abstract 2163: Microtubule-dependent regulation of a constitutively active androgen receptor splice variant
by Thadani-Mulero, Maria and Plymate, Stephen R and Giannakakou, Paraskevi
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 8 Supplement, pp. 2163 - 2163
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Ar-variant–positive CTC: A surrogate for a surrogate for taxane therapy outcome?
by Dehm, Scott M and Montgomery, Bruce and Plymate, Stephen R
Clinical Cancer Research, ISSN 1078-0432, 2019, Volume 25, Issue 6, pp. 1696 - 1698
Circulating tumor cells' (CTC) biomarkers may become indicators for selection of therapy. The presence of androgen receptor (AR)-variant-positive CTCs may be... 
ONCOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shadding in prostate cancer
by Wu, Jennifer D and Higgins, Lily M and Steinle, Alexander and Cosman, David and Haugk, Kathy and Plymate, Stephen R
Journal of Clinical Investigation, ISSN 0021-9738, 08/2004, Volume 114, Issue 4, pp. 560 - 568
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
by Cao, Bo and Qi, Yanfeng and Zhang, Guanyi and Xu, Duo and Zhan, Yang and Alvarez, Xavier and Guo, Zhiyong and Fu, Xueqi and Plymate, Stephen R and Sartor, Oliver and Zhang, Haitao and Dong, Yan
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 6, pp. 1646 - 1656
Upregulation of constitutively-active androgen receptor splice variants (AR-Vs) has been implicated in AR-driven tumor progression in castration-resistant... 
Castration resistance | Splice variant | Enzalutamide | Prostate cancer | Androgen receptor | Apoptosis - drug effects | Humans | Transcriptional Activation | Male | Protein Transport - drug effects | Promoter Regions, Genetic - genetics | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Neoplasms, Hormone-Dependent - genetics | Cell Nucleus - metabolism | Chromatin Immunoprecipitation | RNA Splicing - genetics | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Real-Time Polymerase Chain Reaction | Phenylthiohydantoin - pharmacology | RNA, Messenger - genetics | Prostatic Neoplasms, Castration-Resistant - drug therapy | Reverse Transcriptase Polymerase Chain Reaction | Phenylthiohydantoin - analogs & derivatives | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Receptors, Androgen - genetics | Androgens - pharmacology | Mice, Nude | Neoplasms, Hormone-Dependent - pathology | Protein Isoforms | Cell Proliferation - drug effects | Mice | Neoplasms, Hormone-Dependent - drug therapy | Subcellular Fractions
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
by Shan Wang and Rahul K. Kollipara and Nishi Srivastava and Rui Li and Preethi Ravindranathan and Elizabeth Hernandez and Eva Freeman and Caroline G. Humphries and Payal Kapur and Yair Lotan and Ladan Fazli and Martin E. Gleave and Stephen R. Plymate and Ganesh V. Raj and Jer-Tsong Hsieh and Ralf Kittler
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2014, Volume 111, Issue 11, pp. 4251 - 4256
The transcription factor E-twenty-six related gene (ERG), which is overexpressed through gene fusion with the androgen-responsive gene transmembrane protease,... 
Cell growth | Epithelial cells | Cell lines | Small interfering RNA | Antibodies | Prostate cancer | Prostate | Heterologous transplantation | Tumors | Vehicles | ANDROGEN RECEPTOR | GENE FUSIONS | CELLS | APOPTOSIS | NETWORK | MULTIDISCIPLINARY SCIENCES | PTEN | TMPRSS2 | EXPRESSION | PROGRESSION | Transcriptional Regulator ERG | Endopeptidases - metabolism | Nitriles - pharmacology | Humans | Oncogene Proteins - metabolism | Male | Cyanoacrylates | Protease Inhibitors - pharmacology | Animals | Ubiquitination - drug effects | RNA Interference | Prostatic Neoplasms - enzymology | Cell Proliferation - drug effects | Mice | Pyridines - pharmacology | Transcription Factors | HeLa Cells | Prostatic Neoplasms - drug therapy | Prevention | Analysis | Development and progression | Diagnosis | Health aspects | Gene fusion | Oncogenic viruses | Cancer | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights